hydroxychloroquine and Myositis
hydroxychloroquine has been researched along with Myositis in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Myositis: Inflammation of a muscle or muscle tissue.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"In this study we investigated COVID-19 vaccination-related adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory myopathies (IIMs) and other systemic autoimmune and inflammatory disorders (SAIDs)." | 1.72 | COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies. ( Agarwal, V; Aggarwal, R; Cavagna, L; Chatterjee, T; Chinoy, H; Day, J; Distler, O; Gaur, PS; Gheita, T; Gil-Vila, A; Gonzalez, RA; Gracia-Ramos, AE; Gupta, L; Joshi, M; Kardes, S; Kim, M; Knitza, J; Kuwana, M; Lilleker, JB; Makol, A; Milchert, M; Nikiphorou, E; Nune, A; Parodis, I; Ravichandran, N; Saavedra, MA; Salim, B; Selva-O'Callaghan, A; Sen, P; Shinjo, SK; Tan, AL; Velikova, T; Ziade, N, 2022) |
"A control group of 16 patients with idiopathic inflammatory myositis (IIM) on HCQ at time of biopsy but without evidence of CB was identified." | 1.46 | Curvilinear bodies are associated with adverse effects on muscle function but not with hydroxychloroquine dosing. ( Blumbergs, P; Khoo, T; Koszyca, B; Lester, S; Limaye, V; Otto, S; Smith, C, 2017) |
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors
Authors | Studies |
---|---|
Gil-Vila, A | 1 |
Ravichandran, N | 1 |
Selva-O'Callaghan, A | 1 |
Sen, P | 1 |
Nune, A | 1 |
Gaur, PS | 1 |
Gonzalez, RA | 1 |
Lilleker, JB | 1 |
Joshi, M | 1 |
Agarwal, V | 2 |
Kardes, S | 1 |
Kim, M | 1 |
Day, J | 1 |
Makol, A | 1 |
Milchert, M | 1 |
Gheita, T | 1 |
Salim, B | 1 |
Velikova, T | 1 |
Gracia-Ramos, AE | 1 |
Parodis, I | 1 |
Nikiphorou, E | 1 |
Tan, AL | 1 |
Chatterjee, T | 1 |
Cavagna, L | 1 |
Saavedra, MA | 1 |
Shinjo, SK | 1 |
Ziade, N | 1 |
Knitza, J | 1 |
Kuwana, M | 1 |
Distler, O | 1 |
Chinoy, H | 1 |
Aggarwal, R | 1 |
Gupta, L | 1 |
Uslu, S | 1 |
Bozkirli, DE | 1 |
Kozanoglu, I | 1 |
Bozkirli, E | 1 |
Yucel, E | 1 |
Khoo, T | 1 |
Otto, S | 1 |
Smith, C | 1 |
Koszyca, B | 1 |
Lester, S | 1 |
Blumbergs, P | 1 |
Limaye, V | 1 |
LOUYOT, P | 1 |
GAUCHER, A | 1 |
JEANBLANC, J | 1 |
MONTET, Y | 1 |
Muirden, KD | 1 |
Ponge, T | 1 |
Mussini, JM | 1 |
Ponge, A | 1 |
Forgeau, Y | 1 |
Barrier, J | 1 |
Cottin, S | 1 |
Grolleau, JY | 1 |
Reviews
1 review available for hydroxychloroquine and Myositis
Article | Year |
---|---|
The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
Topics: Anti-Glomerular Basement Membrane Disease; Arthritis, Rheumatoid; Captopril; Chloroquine; Clinical T | 1986 |
Trials
1 trial available for hydroxychloroquine and Myositis
Article | Year |
---|---|
The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
Topics: Anti-Glomerular Basement Membrane Disease; Arthritis, Rheumatoid; Captopril; Chloroquine; Clinical T | 1986 |
Other Studies
6 other studies available for hydroxychloroquine and Myositis
Article | Year |
---|---|
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
Topics: Adult; Animals; Autoimmune Diseases; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Exanthema; Female; | 2022 |
Myositis due to COVID-19.
Topics: Adult; Amides; Antiviral Agents; C-Reactive Protein; COVID-19; COVID-19 Nucleic Acid Testing; Creati | 2021 |
Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
Topics: Aged; Autoantibodies; Azathioprine; Combined Modality Therapy; Creatine Kinase; Cyclophosphamide; Em | 2013 |
Curvilinear bodies are associated with adverse effects on muscle function but not with hydroxychloroquine dosing.
Topics: Antirheumatic Agents; Databases, Factual; Humans; Hydroxychloroquine; Muscle Weakness; Muscle, Skele | 2017 |
[EVALUATION OF LONG-TERM THERAPY WITH CHLOROQUINE AND HYDROXYCHLOROQUINE IN RHEUMATOLOGY].
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Drug Therapy; Humans; Hydrarthrosis; Hydroxychloroqui | 1964 |
[Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine].
Topics: Female; Humans; Hydroxychloroquine; Middle Aged; Myositis; Sjogren's Syndrome | 1987 |